ReShape Lifesciences Inc. (RSLS)
USD 0.49
(29.26%)
USD 0.49
(29.26%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -11.38 Million USD | 75.36% |
| 2022 | -46.21 Million USD | 25.38% |
| 2021 | -61.93 Million USD | -186.33% |
| 2020 | -21.63 Million USD | 70.85% |
| 2019 | -74.2 Million USD | 8.56% |
| 2018 | -81.15 Million USD | -139.97% |
| 2017 | -33.81 Million USD | -44.76% |
| 2016 | -23.36 Million USD | 8.39% |
| 2015 | -25.49 Million USD | 2.41% |
| 2014 | -26.12 Million USD | -1.35% |
| 2013 | -25.78 Million USD | -9.89% |
| 2012 | -23.46 Million USD | 9.76% |
| 2011 | -25.99 Million USD | -49.87% |
| 2010 | -17.34 Million USD | 45.67% |
| 2009 | -31.92 Million USD | 15.7% |
| 2008 | -37.87 Million USD | -32.54% |
| 2007 | -28.57 Million USD | -61.53% |
| 2006 | -17.69 Million USD | -57.74% |
| 2005 | -11.21 Million USD | -225.2% |
| 2004 | -3.44 Million USD | -81.42% |
| 2003 | -1.9 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.19 Million USD | -29.15% |
| 2024 Q2 | -1.59 Million USD | 27.27% |
| 2023 Q3 | -3.53 Million USD | -1.17% |
| 2023 Q2 | -3.49 Million USD | -31.22% |
| 2023 Q1 | -2.66 Million USD | 83.98% |
| 2023 FY | -11.38 Million USD | 75.36% |
| 2023 Q4 | -1.69 Million USD | 51.95% |
| 2022 Q1 | -8.21 Million USD | 76.83% |
| 2022 Q2 | -9.44 Million USD | -14.96% |
| 2022 FY | -46.21 Million USD | 25.38% |
| 2022 Q4 | -16.61 Million USD | -36.32% |
| 2022 Q3 | -12.18 Million USD | -29.03% |
| 2021 Q2 | -3.9 Million USD | 19.94% |
| 2021 Q1 | -4.87 Million USD | 42.9% |
| 2021 Q3 | -17.69 Million USD | -353.59% |
| 2021 Q4 | -35.45 Million USD | -100.34% |
| 2021 FY | -61.93 Million USD | -186.33% |
| 2020 Q1 | -4.31 Million USD | 82.8% |
| 2020 FY | -21.63 Million USD | 70.85% |
| 2020 Q3 | -5.17 Million USD | -43.7% |
| 2020 Q4 | -8.53 Million USD | -64.82% |
| 2020 Q2 | -3.6 Million USD | 16.4% |
| 2019 Q3 | -28.75 Million USD | -80.62% |
| 2019 Q2 | -15.92 Million USD | -255.67% |
| 2019 FY | -74.2 Million USD | 8.56% |
| 2019 Q4 | -25.05 Million USD | 12.86% |
| 2019 Q1 | -4.47 Million USD | 83.82% |
| 2018 Q3 | -7 Million USD | 80.13% |
| 2018 FY | -81.15 Million USD | -139.97% |
| 2018 Q1 | -11.23 Million USD | -16.8% |
| 2018 Q2 | -35.25 Million USD | -213.8% |
| 2018 Q4 | -27.66 Million USD | -294.94% |
| 2017 Q1 | -7.36 Million USD | -66.13% |
| 2017 Q3 | -9.99 Million USD | -46.1% |
| 2017 Q2 | -6.84 Million USD | 7.15% |
| 2017 Q4 | -9.61 Million USD | 3.77% |
| 2017 FY | -33.81 Million USD | -44.76% |
| 2016 Q4 | -4.43 Million USD | 32.01% |
| 2016 FY | -23.36 Million USD | 8.39% |
| 2016 Q2 | -4.99 Million USD | 32.58% |
| 2016 Q1 | -7.4 Million USD | -9.42% |
| 2016 Q3 | -6.52 Million USD | -30.58% |
| 2015 Q1 | -7.17 Million USD | -16.07% |
| 2015 Q4 | -6.77 Million USD | -63.13% |
| 2015 Q3 | -4.15 Million USD | 43.94% |
| 2015 Q2 | -7.4 Million USD | -3.2% |
| 2015 FY | -25.49 Million USD | 2.41% |
| 2014 Q1 | -6.73 Million USD | -2.42% |
| 2014 Q2 | -7.5 Million USD | -11.43% |
| 2014 Q4 | -6.18 Million USD | -8.17% |
| 2014 Q3 | -5.71 Million USD | 23.82% |
| 2014 FY | -26.12 Million USD | -1.35% |
| 2013 Q1 | -6.58 Million USD | 6.35% |
| 2013 Q2 | -6.32 Million USD | 3.92% |
| 2013 Q3 | -6.3 Million USD | 0.32% |
| 2013 Q4 | -6.57 Million USD | -4.28% |
| 2013 FY | -25.78 Million USD | -9.89% |
| 2012 Q1 | -5.63 Million USD | 30.08% |
| 2012 Q3 | -5.84 Million USD | -18.03% |
| 2012 Q4 | -7.02 Million USD | -20.18% |
| 2012 Q2 | -4.95 Million USD | 12.05% |
| 2012 FY | -23.46 Million USD | 9.76% |
| 2011 Q1 | -5.08 Million USD | -28.6% |
| 2011 Q2 | -5.55 Million USD | -9.26% |
| 2011 Q3 | -7.29 Million USD | -31.33% |
| 2011 Q4 | -8.05 Million USD | -10.39% |
| 2011 FY | -25.99 Million USD | -49.87% |
| 2010 Q3 | -4.38 Million USD | -2.96% |
| 2010 FY | -17.34 Million USD | 45.67% |
| 2010 Q1 | -4.74 Million USD | -64.28% |
| 2010 Q2 | -4.25 Million USD | 10.3% |
| 2010 Q4 | -3.95 Million USD | 9.81% |
| 2009 FY | -31.92 Million USD | 15.7% |
| 2009 Q4 | -2.89 Million USD | 75.93% |
| 2009 Q1 | -6.66 Million USD | 14.73% |
| 2009 Q2 | -10.36 Million USD | -55.37% |
| 2009 Q3 | -12 Million USD | -15.88% |
| 2008 Q4 | -7.82 Million USD | 23.31% |
| 2008 Q1 | -8.49 Million USD | 2.84% |
| 2008 Q2 | -11.35 Million USD | -33.61% |
| 2008 Q3 | -10.19 Million USD | 10.17% |
| 2008 FY | -37.87 Million USD | -32.54% |
| 2007 Q1 | -6.6 Million USD | -26.51% |
| 2007 Q3 | -6.6 Million USD | 0.0% |
| 2007 FY | -28.57 Million USD | -61.53% |
| 2007 Q4 | -8.74 Million USD | -32.32% |
| 2007 Q2 | -6.6 Million USD | 0.0% |
| 2006 FY | -17.69 Million USD | -57.74% |
| 2006 Q2 | -4.15 Million USD | 0.0% |
| 2006 Q4 | -5.22 Million USD | -25.74% |
| 2006 Q3 | -4.15 Million USD | 0.0% |
| 2006 Q1 | -4.15 Million USD | -48.2% |
| 2005 Q2 | -2.8 Million USD | 0.0% |
| 2005 FY | -11.21 Million USD | -225.2% |
| 2005 Q1 | -2.8 Million USD | 0.0% |
| 2005 Q4 | -2.8 Million USD | 0.0% |
| 2005 Q3 | -2.8 Million USD | 0.0% |
| 2004 FY | -3.44 Million USD | -81.42% |
| 2003 FY | -1.9 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 81.52% |
| BrainsWay Ltd. | -4.19 Million USD | -171.313% |
| Cerus Corporation | -37.48 Million USD | 69.626% |
| Envoy Medical, Inc. | -29.9 Million USD | 61.927% |
| electroCore, Inc. | -18.83 Million USD | 39.54% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -28.667% |
| IceCure Medical Ltd | -14.65 Million USD | 22.284% |
| Inogen, Inc. | -102.44 Million USD | 88.885% |
| OrthoPediatrics Corp. | -20.97 Million USD | 45.709% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 78.379% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 17.157% |
| MaxCyte, Inc. | -37.92 Million USD | 69.973% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 3.984% |
| Nexalin Technology, Inc. | -4.64 Million USD | -144.95% |
| Orthofix Medical Inc. | -151.39 Million USD | 92.479% |
| PAVmed Inc | -64.17 Million USD | 82.256% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 78.297% |
| RxSight, Inc. | -48.6 Million USD | 76.574% |
| Sight Sciences, Inc. | -55.54 Million USD | 79.5% |
| SI-BONE, Inc. | -43.33 Million USD | 73.724% |
| TELA Bio, Inc. | -46.66 Million USD | 75.598% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 77.009% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 16.167% |
| Acutus Medical, Inc. | -81.66 Million USD | 86.056% |
| Talis Biomedical Corporation | -62 Million USD | 81.636% |
| Spectral AI, Inc. | -20.85 Million USD | 45.397% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 81.264% |
| CVRx, Inc. | -41.19 Million USD | 72.361% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1878.674% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -3.941% |
| Bioventus Inc. | -156.23 Million USD | 92.711% |
| Venus Concept Inc. | -37.25 Million USD | 69.431% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 80.712% |
| LivaNova PLC | 17.54 Million USD | 164.898% |
| 908 Devices Inc. | -36.39 Million USD | 68.716% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 93.899% |
| Nemaura Medical Inc. | -14.14 Million USD | 19.491% |
| NeuroPace, Inc. | -32.95 Million USD | 65.448% |
| LENSAR, Inc. | -14.38 Million USD | 20.83% |
| Apyx Medical Corporation | -18.71 Million USD | 39.149% |
| Cutera, Inc. | -162.83 Million USD | 93.007% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -5.143% |
| BioSig Technologies, Inc. | -29.04 Million USD | 60.79% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 86.225% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 48.449% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 116.81% |
| Axonics, Inc. | -6.08 Million USD | -87.04% |
| Outset Medical, Inc. | -172.79 Million USD | 93.41% |
| IRIDEX Corporation | -9.57 Million USD | -18.986% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 89.247% |
| IRadimed Corporation | 17.19 Million USD | 166.231% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -38.125% |
| INVO Bioscience, Inc. | -8.03 Million USD | -41.724% |
| Telesis Bio, Inc. | -47.72 Million USD | 76.14% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 211.169% |
| Varex Imaging Corporation | -47.7 Million USD | 76.128% |
| Quipt Home Medical Corp. | -2.78 Million USD | -309.016% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -0.895% |
| Pulmonx Corporation | -60.84 Million USD | 81.285% |
| Dynatronics Corporation | -2.69 Million USD | -322.097% |
| Modular Medical, Inc. | -17.47 Million USD | 34.82% |
| Semler Scientific, Inc. | 20.58 Million USD | 155.322% |
| InMode Ltd. | 197.91 Million USD | 105.753% |
| Bruker Corporation | 427.2 Million USD | 102.665% |
| Cytosorbents Corporation | -28.5 Million USD | 60.056% |
| DexCom, Inc. | 541.5 Million USD | 102.103% |
| Align Technology, Inc. | 445.05 Million USD | 102.559% |
| Viveve Medical, Inc. | -22.02 Million USD | 48.304% |
| ZimVie Inc. | -393.28 Million USD | 97.105% |
| Movano Inc. | -29.28 Million USD | 61.114% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 6.264% |
| Nexalin Technology, Inc. | -4.64 Million USD | -144.95% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1878.674% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 94.885% |
| Profound Medical Corp. | -28.56 Million USD | 60.142% |
| Insulet Corporation | 206.3 Million USD | 105.52% |
| enVVeno Medical Corporation | -23.51 Million USD | 51.578% |
| Surmodics, Inc. | -11.54 Million USD | 1.343% |
| iCAD, Inc. | -4.84 Million USD | -134.929% |
| Nuwellis, Inc. | -20.2 Million USD | 43.654% |
| Biotricity, Inc. | -14.09 Million USD | 19.208% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 90.773% |
| Aethlon Medical, Inc. | -12.2 Million USD | 6.726% |
| InspireMD, Inc. | -19.91 Million USD | 42.825% |
| PAVmed Inc. | -64.17 Million USD | 82.256% |
| BIOLASE, Inc. | -20.63 Million USD | 44.809% |
| Beyond Air, Inc. | -60.24 Million USD | 81.098% |
| FONAR Corporation | 10.56 Million USD | 207.756% |
| AxoGen, Inc. | -21.71 Million USD | 47.564% |
| Vivani Medical, Inc. | -25.65 Million USD | 55.61% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 139.933% |
| Inari Medical, Inc. | -1.63 Million USD | -596.027% |
| UFP Technologies, Inc. | 44.92 Million USD | 125.347% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -121.868% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -72.394% |
| Tenon Medical, Inc. | -15.58 Million USD | 26.917% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 26.183% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 67.772% |
| AdaptHealth Corp. | -678.89 Million USD | 98.323% |
| Sintx Technologies, Inc. | -8.25 Million USD | -37.874% |
| NanoVibronix, Inc. | -3.71 Million USD | -206.845% |
| Quanterix Corporation | -32.33 Million USD | 64.783% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -0.895% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 2447.835% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 96.288% |
| TransMedics Group, Inc. | -25.02 Million USD | 54.503% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 48.552% |
| NeuroMetrix, Inc. | -6.52 Million USD | -74.393% |
| Hyperfine, Inc. | -44.23 Million USD | 74.26% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 85.495% |
| Biomerica, Inc. | -5.97 Million USD | -90.482% |
| Bone Biologics Corporation | -8.94 Million USD | -27.247% |
| AVITA Medical, Inc. | -39.16 Million USD | 70.928% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -14.398% |
| Silk Road Medical, Inc | -55.74 Million USD | 79.572% |